BWA
48
2
EFX
38
2
WEC
53
-2
LRCX
43
-2
ZION
65
2
MCD
52
2
SYK
64
-4
MA
64
7
DNB
82
4
NEE
50
-5
GE
67
2
BF.B
33
2
PPL
54
-5
HON
67
2
SCHW
62
-2
HP
48
3
VMC
57
4
LH
43
-2
GPC
40
3
DG
6
2
BWA
48
2
EFX
38
2
WEC
53
-2
LRCX
43
-2
ZION
65
2
MCD
52
2
SYK
64
-4
MA
64
7
DNB
82
4
NEE
50
-5
GE
67
2
BF.B
33
2
PPL
54
-5
HON
67
2
SCHW
62
-2
HP
48
3
VMC
57
4
LH
43
-2
GPC
40
3
DG
6
2
Financhill
Back

BridgeBio Pharma Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57

BBIO
BridgeBio Pharma

Last Price:
23.44
Seasonality Move:
10.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 29.5% based on the past 5 years of stock performance.
  • BridgeBio Pharma has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $23.42. The Score for BBIO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 29.5% based on the past 5 years of stock performance.

BridgeBio Pharma Stock Rating

Buy
57
BridgeBio Pharma (BBIO) is a Buy

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
44.32
52-Week Low:
21.62

Prediction Charts

Market Cap:
4.43B
Price in USD:
23.42
Volume:
2.09M
Beta:
1.07

Technical Analysis

SMA50:
24.96
SMA100:
25.70
SMA200:
27.29
52-Wk Change:
-20.61%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 23.42 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 25.01 25.52 25.55 24.46
Nov-6 26.38 25.61 26.60 25.52
Nov-7 25.57 25.88 26.15 25.34
Nov-8 25.80 27.09 27.27 25.57
Nov-11 27.51 26.11 27.57 26.08
Nov-12 26.16 24.62 26.62 24.09
Nov-13 24.92 24.79 26.00 24.66
Nov-14 24.79 24.11 25.79 24.00
Nov-15 24.30 23.72 24.30 22.92
Nov-18 23.32 22.35 24.25 22.10
Nov-19 22.27 22.54 22.94 21.72
Nov-20 22.42 23.04 23.16 22.05
Nov-21 23.04 23.24 23.63 22.82
Nov-22 23.13 23.42 23.65 22.47

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.35 per share, and a decrease next year of $2.41 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.